Summit Therapeutics PLC (SMMT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.32B
Last updated: Nov 17, 2026 at 11:06 AM ET
Summit Therapeutics PLC (SMMT) Competitors
The companies most similar to Summit Therapeutics are TG Therapeutics (TGTX), Spyre Therapeutics (SYRE) and Protagonist Therapeutics (PTGX). By market cap, Summit Therapeutics ranks 5th of the 13 companies on this page; Exelixis (EXEL) is the largest at $16.84B. The median P/E of the 5 companies with a P/E is 27.7x.
Peer Comparison
SMMT's revenue growth of -100.0% is below the peer median of 45.5%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Summit Therapeutics (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Bio-Techne Corp (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| Apogee Therapeutics, Inc. Common Stock (APGE) | $10.22B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Praxis Precision Medicines Inc (PRAX) | $9.17B | N/A | N/A | 0.0% | N/A | 1349.0% | 0.00% |
| Axsome Therapeutics Inc (AXSM) | $7.45B | N/A | 8.6x | -18.2% | -48.1% | 51.9% | 0.00% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Exelixis Inc (EXEL) | $16.84B | 19.3x | 6.9x | 35.4% | N/A | 10.2% | 0.00% |
| Halozyme Therapeutics Inc (HALO) | $11.43B | 17.8x | 6.1x | 26.9% | 15.8% | 39.2% | 0.00% |
| Kymera Therapeutics Inc (KYMR) | $10.89B | N/A | 123.2x | 0.0% | N/A | 466.4% | 0.00% |
| Twist Bioscience Corp (TWST) | $7.40B | N/A | 14.3x | -28.3% | N/A | 27.9% | 0.00% |
| Peer median | $10.05B | 27.7x | 11.1x | 0.0% | 7.7% | 45.5% | 0.00% |
Similar Companies
These are the 12 companies most similar to Summit Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Bio-Techne Corp (TECH) | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments... | TECH competitors |
| Apogee Therapeutics, Inc. Common Stock (APGE) | Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)... | |
| Praxis Precision Medicines Inc (PRAX) | Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal... | PRAX competitors |
| Axsome Therapeutics Inc (AXSM) | Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United... | AXSM competitors |
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| Exelixis Inc (EXEL) | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development... | EXEL competitors |
| Halozyme Therapeutics Inc (HALO) | Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. | HALO competitors |
| Kymera Therapeutics Inc (KYMR) | Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down... | KYMR competitors |
| Twist Bioscience Corp (TWST) | Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. | TWST competitors |
Frequently Asked Questions About SMMT
Who are Summit Therapeutics' main competitors?
The companies most similar to Summit Therapeutics include TG Therapeutics (TGTX), Spyre Therapeutics (SYRE), Protagonist Therapeutics (PTGX), Bio-Techne (TECH) and Apogee Therapeutics, Inc. Common Stock (APGE), listed from the closest match.
Who is Summit Therapeutics' biggest competitor?
Exelixis (EXEL) is the largest of the similar companies at $16.84B; TG Therapeutics (TGTX) is the closest match by business profile, size, sector and industry.
How does SMMT stock compare with its competitors?
SMMT's net margin is 0.0% against a peer median of 0.0%.
Which of Summit Therapeutics' competitors pays a higher dividend?
Summit Therapeutics pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.
Is Summit Therapeutics bigger than its competitors?
No. Summit Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Exelixis (EXEL) at $16.84B.
SMMT pages: Overview, Competitors